Updates

    Investigators at the Richard T. Silver Myeloproliferative Neoplasms (MPN) Center – CR&T’s primary funding initiative – have made important advances in research, while providing compassionate care that enhances and prolongs patients’ lives.

    Scroll down this page for videos on the latest research and a patient advocate’s story of her MPN journey and CR&T’s impact on her life.

    We are deeply grateful to the generous friends who make our achievements possible. If you would like to help CR&T continue our important work in 2024 and beyond, please click here.

    Ruth Fein Revell:  A Patient’s MPN Journey

    Ruth Fein Revell is an accomplished health/science writer whose work has appeared in The New York Times and many other media outlets. The many health challenges she has faced – including 25+ years progressing from one MPN to another – in addition to early colon cancer and now myelofibrosis – have made her a dynamic MPN patient advocate.

    In the video below, introduced by CR&T’s president, Tom Silver, Ruth tells her story and explains why CR&T and the Silver Center are close to her heart.

    Thank you for sharing our commitment to prolonging and enhancing the lives of patients like Ruth. And warmest wishes for a very happy and healthy New Year from our CR&T family to yours!

    CR&T-Funded Study: Normal Life Expectancy is Possible for Polycythemia Vera Patients

    In December, the Annual Meeting of the American Society of Hematology
    will feature studies by CR&T-funded researchers at the Richard T. Silver, MD Myeloproliferative Neoplasms (MPN) Center at Weill Cornell Medicine. 

    In the brief video below, Ghaith Abu Zeinah, MD, discusses one of these studies, which shows that polycythemia vera (PV) patients treated at the Silver MPN Center may have a lifespan approaching normal compared to the PV population in the U.S. overall. The practices outlined in this study could lead to new guidelines for monitoring and treating PV at centers nationwide and abroad. These dramatic results are due to the innovative treatment and multi-disciplinary care that patients receive at the Silver Center. 

    This outstanding research was made possible by generous friends like you.

    Please help CR&T continue our support of this life-changing work by making a year-end contribution today. Thank you for making a difference – and warm wishes to you and yours for a happy and healthy holiday season!